Chemical Proteomic Analysis Reveals Alternative Modes of Action for Pyrido[2,3-d]pyrimidine Kinase Inhibitors
Open Access
- 1 December 2004
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 3 (12) , 1181-1193
- https://doi.org/10.1074/mcp.m400124-mcp200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Synthesis and Target Identification of Hymenialdisine AnalogsChemistry & Biology, 2004
- Synthesis and Target Identification of Hymenialdisine AnalogsChemistry & Biology, 2004
- An analysis of the proteomic profile for Thermoanaerobacter tengcongensis under optimal culture conditionsProteomics, 2004
- Beyond Herceptin and GleevecCurrent Opinion in Chemical Biology, 2003
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Identification of SRPK1 and SRPK2 as the Major Cellular Protein Kinases Phosphorylating Hepatitis B Virus Core ProteinJournal of Virology, 2002
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Combinations of ERK and p38 MAPK Inhibitors Ablate Tumor Necrosis Factor-α (TNF-α) mRNA InductionJournal of Biological Chemistry, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Identification of tyrosine 67 in bovine brain myelin basic protein as a specific phosphorylation site for thymus p56lckBiochemical and Biophysical Research Communications, 1991